# Atelvia

NDC: 0430-0979
Generic name: risedronate sodium
Labeler / Manufacturer: Allergan, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20101201

FDA application: NDA022560

## Active ingredients

- RISEDRONATE SODIUM HEMIPENTAHYDRATE: 30.1 mg/1
- RISEDRONATE SODIUM MONOHYDRATE: 4.9 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0430-0979"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0430-0979
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8b9ab88-1a26-46c3-80ec-4eaa45202021